NCT04159961View on ClinicalTrials.gov

Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 24, 2019

Primary Completion Date

April 21, 2020

Study Completion Date

April 21, 2020

Conditions
Healthy
Interventions
DRUG

DWJ211

Inject the Drug into submental fat and abdominal fat via subcutaneous

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY